DxS Ltd, a personalized medicine company, has granted DuPont Qualicon, a developer of science-based diagnostic products that can reduce the impact of pathogens and other unwelcome organisms in food and pharmaceuticals, a license to use its novel Scorpions® diagnostic platform to develop tests for use by the food industry. The deal will allow DuPont Qualicon to use DxS Scorpion technology, a highly sensitive and adaptable platform, to develop multiplex assays for detecting microorganisms that affect food safety and quality. Scorpions is a homogeneous, closed-tube platform for PCR analysis for which DxS own the worldwide IP. The technology has been designed by the company to provide an accurate, rapid and reliable fluorescence-based signal generation system with application rights in in-vitro diagnostics, genetic analysis, biothreat detection, environmental utility and now also food and drink microbial testing. Kevin Huttman, President of DuPont Qualicon said: “With Scorpions’ cutting-edge technology, we can develop increasingly faster, more sensitive tests for pathogens and spoilage organisms that anticipate and satisfy the evolving needs of the food industry for safer, higher quality products.” Financial terms were not disclosed.
DxS Grants DuPont License to Scorpions Technology for Food and Beverage Diagnostics
News Feb 03, 2009
Creating mutations in a key Ebola virus protein that helps the deadly virus escape from the body's defenses can make the virus unable to produce sickness and activate protective immunity in the infected host, according to a study by the Institute for Biomedical Sciences at Georgia State University.READ MORE